2019 - Updates & Insights Blog
-
A key bottleneck in precision oncology is the lack of knowledge of the function of most cancer variants. CTD2 Network researchers discuss cellular profiling methods to assess the functional impact of variants.
-
In HCMI's interactive, searchable online catalog, users can query, view, and download model-associated data. HCMI is developing next-generation cancer models from several cancer types including rare cancers.
-
The Beat AML project integrates molecular, drug response, and clinical data for progress towards individualized therapies for acute myeloid leukemia patients. Dr. Jeffrey Tyner from Oregon Health and Science University describes the collaborative effort.
-
Brain cancers are notoriously hard to study, model, and treat. Dr. Mario Suvà speaks about how single-cell RNA sequencing is helping researchers gain clarity on the origins, development, and response to treatment for these cancers.